Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Bellevue Life Sciences Acquisition Corp.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21
   10-K10-K
Revenues  0.10.0
            Revenue growth  969.8% 
Cost of goods sold  0.00.0
Gross profit  0.10.0
            Gross margin  100.0%100.0%
Selling, general and administrative  0.00.0
EBIT   [+]0.00.0
            EBIT margin  50.0%50.0%
Other income (expense), net  -0.10.0
Pre-tax income  0.00.0
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  0.00.0
            Net margin  -50.0%-50.0%
   
Basic EPS   [+]($0.02)$0.00
Diluted EPS   [+]($0.02)$0.00
   
Shares outstanding (basic)  1.51.5
Shares outstanding (diluted)  1.51.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy